- Udyam number
- UDYAM-CH-01-0002998

About Addii Biotech Private Limited
Data last updated:
Addii Biotech Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC033281. Its GSTIN is 04AAKCA8353P1Z5 (Chandigarh). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.67 Cr. It is led by directors Lalit Dogra and Bijaya Kumar Mohanty.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B. No. 60 Phase – II Industrial Area Chandigarh, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.32 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Cr (net margin 2.5%) and EBITDA of ₹5.44 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 29% over five years.
The company has about 246 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Addii Biotech. As per MCA filings, the company has open charges of ₹35.3 Cr and satisfied charges of ₹21.3 Cr on record. Court records list 121 cases involving the company, including 109 filed by the company and 13 filed against it; 104 cases are pending. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹84.2 Lakh; the latest was in May 2018.
Addii Biotech Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0002998). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website addiibiotech.com.
Company details
Recognitions & Rankings of Addii Biotech
Contact details
Addii Biotech Private Limited's registered office is in Chandigarh, Chandigarh. Its website is addiibiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB. No. 60 Phase – II Industrial Area Chandigarh, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Addii Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Addii Biotech operates one associated brand: ADDII BIOTECH. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and supply of therapeutic drugs in India. | addiibiotech.com |
Business activity
The main business activity of Addii Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Addii Biotech Private Limited, buy the company report.
Financials of Addii Biotech Private Limited
FY 2024 filings availableAddii Biotech Private Limited reported revenue of ₹100.32 Cr (up 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 59% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Addii Biotech Private Limited, buy the company report.
Board of directors of Addii Biotech Private Limited
Addii Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Dogra | Director | 27 Sep 2011 | 15 Years 0 Months | Current |
| Bijaya Kumar Mohanty | Director | 28 May 2018 | 8 Years 4 Months | Current |
Auditor
Addii Biotech Private Limited is audited by AMAN SHARMA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMAN SHARMA | FY 2024 | 556514 |
Shareholding
The shareholding of Addii Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Addii Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2025 | 101173454 | Sidbi | ₹60.42 Lakh | Open | |
| 29 Sep 2025 | 101173456 | Sidbi | ₹1.46 Cr | Open | |
| 20 Mar 2025 | 101066190 | Hdfc Bank Limited | ₹55 Lakh | Open | |
| 27 Nov 2024 | 101010579 | Others | ₹24.88 Lakh | Open | |
| 02 Jan 2024 | 100858573 | Others | ₹35 Lakh | Open |
To see the full charge records of Addii Biotech Private Limited, buy the company report.
Total charge records: 21 View all charges
Deals & funding
Addii Biotech Private Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹84.2 Lakh; the latest was in May 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2016 | Rights issue | ₹81.5 Lakh | Investors: an individual |
| Aug 2016 | Funding round | ₹35.2 Lakh | Investors: an individual |
| Aug 2014 | Funding round | ₹49 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Addii Biotech Private Limited has 121 court cases on record: 109 filed by Addii Biotech, 13 filed against it. 104 cases are pending and 17 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 113 | 5 | 97 |
| High courts | 8 | 8 | 7 |
Cases on record (5 of 121)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Laboratoires Griffon Private Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Laboratoires Griffon Private Limited | Pending |
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed by the company against M/S Healease Pharma Pvt. Ltd. and 1 other | Pending |
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed by the company against M/S Superior Pharmaceutical India Pvt. Ltd. and 2 others | Pending |
| High Court | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited and 1 other | Pending |
To see the full case history of Addii Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Addii Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Addii Biotech Private Limited has a workforce of 246 employees on its EPFO records as of Aug 31, 2024, across 1 active EPFO establishment.
GST
Addii Biotech has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAKCA8353P1Z5 | Chandigarh | Active | 01 Jul 2017 |
| 02AAKCA8353P1Z9 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAKCA8353P2Z6 | Punjab | Active | 05 Apr 2024 |
To see the full GST registrations and return filing status of Addii Biotech Private Limited, buy the company report.
Recent activity
Addii Biotech Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Bijaya Kumar Mohanty was appointed as Director on 28 May 2018.
23 earlier events are in the company report.
Frequently asked questions
Addii Biotech is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 2011 (15+ years old) and is registered under CIN U24232CH2011PTC033281.
Addii Biotech has 2 current directors:
- Lalit Dogra - Director
- Bijaya Kumar Mohanty - Director
The latest financial statements of Addii Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Addii Biotech is 04AAKCA8353P1Z5, registered in Chandigarh. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 02AAKCA8353P1Z9 (Himachal Pradesh), 03AAKCA8353P2Z6 (Punjab).
The CIN (Corporate Identification Number) of Addii Biotech is U24232CH2011PTC033281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Addii Biotech has 121 court cases on record: 109 filed by the company and 13 filed against it. 104 are pending. Most are in the district courts.
Addii Biotech was incorporated on 27 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
Addii Biotech has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹84.2 Lakh; the latest was in May 2018.
Bijaya Kumar Mohanty was appointed as Director on 28 May 2018. Santosh Kumar ceased to be Director on 28 Apr 2018. Lalit Dogra was appointed as Director on 27 Sep 2011.
Yes, Addii Biotech is registered as an MSME under Udyam registration (number: UDYAM-CH-01-0002998).